Filed:
Oct 29, 2003
Published:
May 27, 2004
Abstract
Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain thioether functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.
Inventors
-
RADMER MATTHEW R
-
DELLARIA JOSEPH F
-
MERRILL BRYON A
Application Number
10696684
Priority Claims
US25421800